Dudediligence.

MoonLake Immunotherapeutics

MLTXNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$84.0M

8 notices · 4,913,778 sh

Oct 2025 to Oct 2026

Reported ·

$77.8M

19 sales · 1 buy · $98,808 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

10 of 19 reported sales carry the 10b5-1 box. Together they are 5.42% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-07-15: Reich Kristian, Form 1442026-06-30: Santos da Silva Jorge, Form 1442026-06-15: Reich Kristian, Form 1442026-04-10: Jorge Pedro Santos Radeck D Silva, Form 1442026-04-09: Bodenstedt Matthias, Form 1442026-03-31: BVF PARTNERS L P/IL, Form 1442025-12-08: Jorge Pedro Santos Radeck Da Silva, Form 1442025-12-08: Kristian Dieter Johannes Reich, Form 1442025-10-08: Bodenstedt Matthias, bought2025-12-08: Reich Kristian, sold2025-12-08: Santos da Silva Jorge, sold2026-03-31: BIOTECHNOLOGY VALUE FUND L P, sold2026-04-09: Bodenstedt Matthias, sold2026-04-10: Santos da Silva Jorge, sold2026-04-14: Bodenstedt Matthias, sold2026-05-11: Bodenstedt Matthias, sold2026-06-15: Reich Kristian, sold2026-06-17: Bodenstedt Matthias, sold2026-06-22: Bodenstedt Matthias, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-07-15Reich Kristian, Chief Scientific Officer$2,916,000
150,000 shplan 2026-03-10Form 4s on file end Jun 23144 ↗
2026-06-30Santos da Silva Jorge, Chief Executive Officer$3,004,500
150,000 shplan 2026-03-31Form 4s on file end Jun 23144 ↗
2026-06-15Reich Kristian, Chief Scientific Officer$2,850,000
150,000 shplan 2026-03-10144 ↗
Form 4, 2026-06-17: sold 150,000 at $19.01 Form 4 ↗
2026-04-10Jorge Pedro Santos Radeck D Silva, Chief Executive Officer$2,787,000
150,000 shplan 2026-03-31144 ↗
Form 4, 2026-04-14: sold 150,000 at $18.35 Form 4 ↗
2026-04-09Bodenstedt Matthias, Chief Financial Officer$2,969,660
160,870 shplan 2025-12-10144 ↗
Form 4, 2026-04-10: sold 87,795 at $18.95 Form 4 ↗
2026-03-31BVF PARTNERS L P/IL, 10% Stockholder, Affiliate of Director$63.5M
3,750,000 shno plan date144 ↗
Form 4, 2026-04-02: sold 3,750,000 at $16.79 Form 4 ↗
2025-12-08Jorge Pedro Santos Radeck Da Silva, Chief Executive Officer$2,980,000
200,000 shno plan date144 ↗
Form 4, 2025-12-10: sold 200,000 at $14.87 Form 4 ↗
2025-12-08Kristian Dieter Johannes Reich, Chief Scientific Officer$3,003,038
202,908 shno plan date144 ↗
Form 4, 2025-12-10: sold 202,908 at $14.85 Form 4 ↗